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Introduction: A progress in the management of cardiovascular disease leads to a decrease in mortality, 
but heart failure (HF) seems to be an exception. Today, the rate of rehospitalization and mortality after 
acute heart failure is still very high. Lower ejection fraction (EF) means worse prognosis, but recent 
studies are reporting that HF patients with preserved EF have no better survival compared to patients 
with reduced EF1. Goal: to investigate a possible difference in the outcome of HF patients with reduced 
(HFREF) and preserved ejection fraction (HFPEF). 
Patients and Methods: In 222 patients hospitalized in acute HF (138 with reduced EF and 74 with pre-
served EF) were determined routine laboratory test, including BNP. The LVEF cutoff for diagnosing of 
HFPEF was above 45 %. Patients were followed for the next 18 months for the occurrence of 1. readmis-
sion due to repeat decompensation and 2. mortality. 
Results: BNP at discharge was 
higher in HFREF compared to 
HFPEF group [699.3 (271.8-1519.1) 
pg/ml vs 263.3 (134.4-502.2) pg/
ml, p <0.001]. During 18-month 
follow-up 129 patients (58.11%) 
were readmitted due to decom-
pensation, but there was no 
significant difference between 
group: in HFREF group was hos-
pitalized 87 (63.04%) patients 
compared to 42 (50%) patients 
in HFPEF group (p=0.077). There 
was no difference in the rate of 
readmission in 1-month (p=0.7), 
6-month (p=0.24), and 12-month 
follow up (p=0.16) in HFREF vs 
HFPEF group. In Kaplan-Meier 
curve there was no significant 
difference in the mean time 
of the occurrence of readmis-
sion due to decompensation: in 
HFREF group 2.2 (95% CI=1.58-
2.8) months and in HFPEF group 
2.33 (95% CI=1.3-3.4) months (p=0.89) (Figure 1). In HFREF 18-month survival was 43.5% (60/138) and in 
HFPEF group was 56.0 % (47/84) and the difference was not significant (p=0,096). In the Kaplan-Meier 
curve, there was no difference in time of survival in 18-month follow-up (p=0.9): mean time of survival 
in HFREF was 3.8 (95% CI=3.0-4.7) months and in HFPEF 3.75 (95% CI=2.5-5.0) months (Figure 2). There 
was no difference in mortality in 1-month (p=0.8), 6-month (p=0.16) and 12-month follow up (p=0.08). 
Conclusion: Rate of rehospitalization due to decompensation and mortality is not different between 
HFREF and HFPEF group. Preserved EF is not related to better survival in patients with HF.
Figure 1.  Admission due to decompensa-
ted heart failure in the group of heart failure 
patients with reduced (HfRef) and preserved 
ejection fraction (Hfpef).
Figure 2.  Kaplan-Meier survival curve in in 
the group of heart failure patients with reduced 
(HfRef) and preserved ejection fraction (Hfpef) 
in an 18-month period.
